Heshuying

Dr. HE is a professor of Microbiology and Biochemical Pharmacy at the College of Life Sciences and Technology, China Pharmaceutical University. She received his Ph.D. degree in pharmacology from China Pharmaceutical University in 2004. Visiting Scholar at the University of Michigan（2012-2013）and Senior Research Scholar at University of Strathclyde (2022) . He presided over the project of raw materials and injection of low molecular weight heparin sodium, and obtained the production certificate approved by the State Drug Administration. Dr. HE has long been committed to the research and development of anti-atherosclerosis drugs and their mechanisms. She has been selected as one of the Six talent Peaks in Jiangsu Province (2008).

1.Umer Ejaz , Fahad Akhtar , Jinbing Xue , Xinyu Wan , Tong Zhang , Shuying He*. Inhibitory potential of low molecular weight Heparin in cell adhesion; emphasis on tumor metastasis, Eur J Pharmacol, 2021,892:173778.

2.Fahad Akhtar, Xinyu Wan, Gang Wu, Samuel Kesse, Shaoda Wang and Shuying He*.Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes, molecules, 2018, 23:1757-1768.

3.Jie-ru Liu, Hui-fang Wang, Dan-feng Yu, Xiao-yu Chen, Shu-ying He*. Modulation of binding to vascular endothelial growth factor and receptor by heparin derived oligosaccharide. Carbohydrate Polymers, 2017, 174:558-564.

4.LIU Jie-Ru, WU Jie, YU Xin-Chao, QIAN Xuan, XIONG Rui, WANG Hui-Fang, YU Dan-Feng, LIU Fei-Fei, HE Shu-Ying*. Heparin-derived oligosaccharide inhibits vascular intimal hyperplasia in balloon-injured carotid artery .Chinese Journal of Natural Medicines, 2017, 15(6): 0442-0450.

5.RUI XIONG, JING SUN, KUN LIU, YUNGEN XU and SHUYING HE*. Effect of CPU-XT-008, a combretastatin A-4 analogue, on the proliferation, apoptosis and expression of vascular endothelial growth factor and basic fibroblast growth factor in human umbilical vein endothelial cells. Oncology Letters, 2016, 11: 491-499.

2012-2015 Ministry of Science and Technology, Major New Drug Development Science and Technology Major Project, 2012ZX09502001-004, polysaccharide drug preparation and quality control key technology

2014-2015 Principle Investigator supported by the Fundamental Research Funds for the Central Universities (No. 12ZJ14143): Study on anti-atherosclerosis mechanism based on new SAP-HDL target

2011-2013: Principle Investigator supported by the Fundamental Research Funds for the Central Universities (No. JKZ2011013): Studies on the anti-proliferative effect of twelve degree of polymerization heparin on vascular smooth muscle cells and its mechanisms

1. National First-class Undergraduate Course in 2023 -- Preparation and Production of Genetic Engineering drugs Virtual Simulation experiment (in charge)

2. The first batch of Jiangsu Provincial first-class undergraduate courses in 2021 -- Preparation and Production of genetic Engineering drugs virtual simulation experiment (in charge)

3. 2020 National First-class Undergraduate Course -- Biopharmaceutical Technology online First-class Course (3/5)

4. 2018 National Open Online Course on Biopharmaceutical Technology (3/5)

Book 1:Chief Editor of 《Biopharmaceutical Technology Experiment and Guidance》, China Medical Science and Technology Press, 2019

Book2: Deputy Editor of 《Biologic Pharmaceutical Analysis》, China Medical Science and Technology Press, 2019